Celebrity Inventors
Actress Jamie Lee Curtis is a patented inventor - she created a diaper equipped with a premoistened baby wipe. And that's no act!
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20120108668 | METABOLIC PROFILES The invention relates to the use of endogenous metabolites to produce a metabolic profile of a disorder or disease in a subject, e.g. an autoimmune disease, in particular rheumatoid arthritis, and the analysis of such metabolic profiles in order to find disturbances in ... | 05/03/2012 |
| 20120022166 | Methods for Modulating Macrophage Proliferation Using Polyamine Analogs Methods for modulating macrophage proliferation in an individual afflicted with or at risk for a macrophage-associated disease are provided. The methods employ a polyamine analog, or salt or protected derivative thereof. Macrophage proliferation has been implicated in a... | 01/26/2012 |
| 20110172258 | INDENE DERIVATIVES AS PHARMACEUTICAL AGENTS Compounds of formula (Ia):
| 07/14/2011 |
| 20110144043 | Stat modulators The present invention is directed to methods, kits and compositions for modulating the activity of Stat molecules (e.g., Stat1, Stat3 and Stat5). The compounds of the invention are useful for treating and/or preventing disorders characterized by Stat dysregulation, such... | 06/16/2011 |
| 20110112199 | PHARMACEUTICAL FOR ORAL DELIVERY COMPRISING MGBG AND METHODS OF TREATING DISEASE Disclosed herein are new oral pharmaceutical compositions of MGBG and related polyamine analogs, polyamine biosynthesis inhibitors, polyamine inhibitors of AMD-I and regulators of osteopontin, and their application for the treatment of disease.... | 05/12/2011 |
| 20110091418 | METHODS FOR TREATING VIRAL INFECTIONS USING POLYAMINE ANALOGS Methods for treating viral infections using polyamine analogs, including mitoguazone (MGBG), are provided. In these methods, polyamine analogs destroy macrophages that act as viral reservoirs, facilitating the destruction of the viruses that dwell within the macrophages... | 04/21/2011 |
| 20100285032 | ESTROGEN RECEPTOR-RELATED RECEPTOR GAMMA (ERR GAMMA) IN BONE AND CARTILAGE FORMATION AND METHODS AND COMPOSITIONS RELATING TO SAME ERRγ is expressed in bone and cartilage in vivo and osteoblastic and chondrocytic cells in vitro. ERRγ is a transcriptional activator of an osteoblast-associated osteopontin (OPN) and chondrocyte-associated (Sox9) gene in osteoblasts and chondrocytes respectively. Kno... | 11/11/2010 |
| 20100196286 | INHALATION DELIVERY METHODS AND DEVICES Methods, devices and kits for treating sleep disorders, anxiety disorders, and developmental disorders, and/or for inducing an arousable state of sedation in a subject, are described. For example, inhalation methods, devices and kits for treating insomnia, anxiety and/o... | 08/05/2010 |
| 20100179225 | POI Prevention A method is provided, comprising administering at least one guanylhydrazone or salt thereof or a combination thereof to a subject to prevent or ameliorate in said subject at least one of postoperative intestinal inflammation, postoperative ileus, ischemia reperfusion in... | 07/15/2010 |
| 20100160332 | a2-Adrenoceptor Ligands The adrenergic receptors or adrenoceptors are a family of G-protein coupled receptors split into α and β subclasses. The adrenoceptors have important roles in regulating a myriad of physiological conditions and their malfunction has been implicated in the pathophysiol... | 06/24/2010 |
| 20100152220 | INDENE DERIVATIVES AS PHARMACEUTICAL AGENTS Compounds of formula (Ia):
| 06/17/2010 |
| 20100152299 | Process for making compositions with poorly compressible therapeutic compounds A process for preparing solid dosage forms that contain poorly compressible therapeutic compound. The process, for example, provides for the inventive use of an extruder, especially a twin screw extruder, to melt granulate a therapeutic compound(s) with a granulation ex... | 06/17/2010 |
| 20100081661 | HEME OXYGENASE INHIBITORS, SCREENING METHODS FOR HEME OXYGENASE INHIBITORS AND METHODS OF USE OF HEME OXYGENASE INHIBITORS FOR ANTIMICROBIAL THERAPY Inhibitors of microbial heme oxygenase and their use for treatment of microbial infections and bioremediation. The inhibitors of microbial heme oxygenase are useful against a new class of antimicrobial agents to target infections that are persistently difficult to comba... | 04/01/2010 |
| 20100069423 | Use of Chk2 Kinase Inhibitors for Cancer Treatment Described herein are Chk2-inhibitor compounds and derivatives thereof, and methods of treating or preventing disease and disease symptoms using the compounds and compositions thereof.... | 03/18/2010 |
| 20100055086 | Antimicrobial Flush Solutions The present invention provides antimicrobial solutions that comprise at least one alcohol, at least one antimicrobial agent and at least one chelator and/or anticoagulant. Also provided are methods for rapidly reducing a microbe or a virus from surfaces including surfac... | 03/04/2010 |
| 20100029725 | RESISTANCE MANAGEMENT STRATEGIES Insect refuge strategies are described for the management of insect resistance development. The present invention relates generally to the control of pests that cause damage to crop plants, and in particular to corn plants, by their feeding activities directed to root d... | 02/04/2010 |
| 20100029773 | Systematic identification of new anti-prion drugs by high-throughput screening based on scanning for intensely fluorescent targets (sift) The present invention relates to a method of identifying a compound for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases, comprising the steps of: (a) bringing into contact a labeled monomeric protei... | 02/04/2010 |
| 20090324580 | Use of Inhibitors of Scavenger Receptor Class Proteins for the Treatment of Infectious Diseases The present invention relates to the use of inhibitors of scavenger receptor class proteins, in particular ScarB1 for the production of a medicament for treatment of and/or prophylaxis against infections, involving liver cells and/or hematopoietic cells, in particular m... | 12/31/2009 |
| 20090298902 | PESTICIDE COMPOSITIONS FOR COMBATING ARTHROPOD PESTS, SNAILS AND NEMATODES The present invention relates to a pesticide composition in the form of a water absorbent granular material and to the use of such compositions for combating arthropod pests, in particular soil-living arthropod pests, and nematodes, with particular preference given to s... | 12/03/2009 |
| 20090239817 | ORGANIC THIOPHOSPHATE ANTIRETROVIRAL AGENTS A method for the prevention or treatment of human immunodeficiency virus infection by administering an effective amount of amifostine, phosphonol, or similar compound to an individual in need is provided.... | 09/24/2009 |
| 20090036540 | Guanylhydrazones in Methods of Treatment or Diagnosis as Modulators of Signal Transduction A method is provided for the treatment of a condition mediated by raf kinase, which includes administering a guanylhydrazone to a subject in need thereof. A method is also provided, which includes modulating or inhibiting signal transduction in a c-raf pathway with at l... | 02/05/2009 |
| 20090018201 | Method of Combating Bugs A method of combating bugs comprising contacting the bugs or their food supply, habitat, breeding grounds or their locus with a pesticidally effective amount of a compound of the formula (I) wherein W is Cl or CF3; X and Y are each independently Cl or Br; R 01/15/2009 | |
| 20080300313 | Solvent Mixture for Preparing Water-Dilutable Liquid Concentrate Formulation of Organic Pesticide Compounds The present invention relates to a solvent mixture SM for preparing a water-dilutable liquid concentrate formulation of sparingly soluble organic pesticide compounds C having a water solubilty of not more than 5 g/l at 25° C./1013 mbar. The present invention also relat... | 12/04/2008 |
| 20080275129 | Methods and Pharmaceutical Compositions for the Treatment of Neurological Damage The invention relates to a method of treating neurological damage, preferably spinal chord injury, said treatment comprising the topical administration of guanabenz. The invention also relates to the use of guanabenz for the preparation of a medicament for the treatment... | 11/06/2008 |
| 20080262092 | REGULATION OF OSTEOPONTIN The present invention provides methods for the regulation of osteopontin activity in a subject as well as for treating or preventing conditions associated with an increased activity of osteopontin activity in a subject.... | 10/23/2008 |
| 20080199606 | Composition for the Impregnation of Fibers, Fabrics and Nettings Imparting a Protective Activity Against Pests Insecticide composition for application to a non-living material, which insecticide composition comprises a mixture including at least one N-arylhydrazine derivative, and at least one polymeric binder; an impregnated non-living material comprising at least one N-arylhyd... | 08/21/2008 |
| 20080194641 | Pesticidal Mixtures Pesticidal mixtures comprising, as active components 1) a compound of the formula I wherein W is CI or CF3; X and Y are each independently CI or Br; R1 is alkyl, alkenyl, alkynyl, or cycloalkyl optionally substituted with 1 to 3 halogens, or alkyl ... | 08/14/2008 |
| 20080181946 | Controlled Release Delivery System For Metformin The invention relates to a controlled release delivery system for Metformin comprising of (a) therapeutically effective amount of Metformin or pharmaceutically acceptable salts there of; (b) hydrophilic polymers and (c) hydrophobic lubricating agent(s). The invention al... | 07/31/2008 |
| 20080070959 | GUANYLHYDRAZONE COMPOUNDS, COMPOSITIONS, METHODS OF MAKING AND USING The present invention relates to compounds having the formula: salts thereof; compositions comprising one or more of the compounds and/or salts thereof; methods of using; and methods of making. ... | 03/20/2008 |
| 20080064687 | Novel thiourea derivatives and the pharmaceutical compositions containing the same The present invention relates to novel thiourea derivatives as a modulator for vanilloid receptor (VR) and the pharmaceutical compositions containing the same. As diseases associated with the activity of vanilloid receptor, pain acute pain, chronic pain, neuropathic pai... | 03/13/2008 |
| 20070292412 | Novel genes and markers in type 2 diabetes and obesity Genes, SNP markers and haplotypes of susceptibility or predisposition to T2D and subdiagnosis of T2D and related medical conditions are disclosed. Methods for diagnosis, prediction of clinical course and efficacy of treatments for T2D, obesity and related phenotypes usi... | 12/20/2007 |
| 20070238789 | PREDNISOLONE ACETATE COMPOSITIONS Prednisolone acetate compositions, and methods, eye drops, and medicaments related thereto, are disclosed herein. ... | 10/11/2007 |
| 20070231267 | Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands The present invention relates to the use of compounds of general formula (I) as ligands to the melanocortin receptors and/or for treatment of disorders in the melanocortin system: wherein X is H or OH; R1, R2, R3, R4 and R5 are the same or different and are selected fro... | 10/04/2007 |
| 20070129442 | N-arylhydrazine derivatives for seed treatment Method for the protection of seeds from soil pests comprising contacting the seeds before sowing and/or after pregermination with a compound of formula I: wherein W is chlorine or trifluoromethyl; X and Y are each independently chlorine or bromine; 06/07/2007 | |
| 20070117868 | Use of n-arylhydrazine derivatives for combating non-crop pests Use of hydrazine derivatives of formula I: wherein W is chlorine or trifluoromethyl; X and Y are each independently chlorine or bromine;
| 05/24/2007 |
| 20070088085 | Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands The present invention relates to the use of compounds of general formula (I) as ligands to the melanocortin receptors and/or for treatment of disorders in the melanocortin system: wherein X is H or OH; R1, R2, R3, R4 and R5 are the same or different and are selected fro... | 04/19/2007 |
| 20060292244 | Use of pvp-iodine liposomes for treatment of acne The invention concerns a method for the production of a pharmaceutical preparation for the treatment of acne forms that is characterized in, that the preparation comprises at least one antiseptic compound associated with a particular carrier. ... | 12/28/2006 |
| 20060293328 | Linear dicationic terphenyls and their aza analogues as antiparasitic agents Novel dicationic terphenyl compounds and their aza analogues. Methods for combating microbial infections with novel dicationic terphenyl compounds and their aza analogues. Processes for synthesizing novel dicationic terphenyl compounds and their aza analogues. ... | 12/28/2006 |
| 20060019883 | Use of cyclin D1 inhibitors The present invention relates to use of certain cyclin D1 inhibitors at the manufacture of pharmaceutical preparations to be used in the treatment of patients to improve their response to tamoxifen treatment following a breast cancer treatment, either surgically, using ... | 01/26/2006 |
| 20050282909 | Guanylhydrazones in methods of treatment or diagnosis as modulators of signal transduction A method is provided for the treatment of a condition mediated by raf kinase, which includes administering a guanylhydrazone to a subject in need thereof. A method is also provided, which includes modulating or inhibiting signal transduction in a c-raf pathway with at l... | 12/22/2005 |
